Please login to the form below
Jazz
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Jazz's Japan sales performance.
J&J puts pressure on rivals with new Erleada okay in prostate cancer
FDA previously granted priority review in this indication
Detecting Alzheimer’s ahead of a cure
A focus on promising new research
Zenopa delivers Communiqué prizes to winners
Publicis Resolute's Georgina Chan, MGP's Peter Sayer and Celgene's Sara Jones win the prizes
FDA starts speedy review of Merck’s Ebola vaccine
First company to file for approval in the US
Biogen loses another pipeline drug to toxicity concerns
Follows discontinuation of Eisai-partnered Alzheimer's drug
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Featured jobs
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
-
Account Director – UK Office
-
Excellent salary and benefits
- Client Services Director- Flexible Working
-
Negotiable
-
Events Executive
-
DOE
- Account Manager – Healthcare advertising
-
Salary TBC
Subscribe to our email news alerts
- Novartis eyes potential new indication for Cosentyx
- J&J's Tremfya filed for approval in US for psoriatic arthritis
- Gracell reports impressive data with one-day CAR-T for leukaemia
- Lucid Group increases footprint in UK, Asia Pacific and Middle East with the acquisition of HealthCare21
- AZ, Merck’s Lynparza scores market-expanding clinical success
- Gracell reports impressive data with one-day CAR-T for leukaemia
- Takeda’s HAE drug Takhzyro backed by NICE
- J&J puts pressure on rivals with new Erleada okay in prostate cancer
- Pharma industry consensus: fix data strategy before pushing artificial intelligence and machine learning applications
- Zenopa delivers Communiqué prizes to winners
- Detecting Alzheimer’s ahead of a cure
- When it’s OK to not be OK: Bedrock breaks down mental health stigma
PMHub
Six Degrees Medical Consulting
For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...
Latest intelligence
- Detecting Alzheimer’s ahead of a cure
- A focus on promising new research...
- Programmatic methodology and why you should be using it
- What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...
- Can you survive without the blue dot?
- Or has the digital world has replaced our brain...
Quick links
Infographics
